Carl Zeiss Meditec AG Stock CINNOBER BOAT
Equities
0DHC
DE0005313704
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
-.--% | -.--% |
Jun. 05 | CARL ZEISS MEDITEC AG : Goldman Sachs reiterates its Sell rating | ZD |
May. 31 | Carl Zeiss Meditec just above annual low - JPMorgan skeptical | DP |
Sales 2024 * | 2.23B 2.39B | Sales 2025 * | 2.51B 2.68B | Capitalization | 7.54B 8.08B |
---|---|---|---|---|---|
Net income 2024 * | 255M 273M | Net income 2025 * | 312M 334M | EV / Sales 2024 * | 3.56 x |
Net Debt 2024 * | 396M 424M | Net Debt 2025 * | 314M 336M | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
29.6
x | P/E ratio 2025 * |
23.9
x | Employees | - |
Yield 2024 * |
1.26% | Yield 2025 * |
1.42% | Free-Float | 40.86% |
Latest transcript on Carl Zeiss Meditec AG
Managers | Title | Age | Since |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 67 | 01-12-31 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
Heike Madan
BRD | Director/Board Member | 52 | 23-03-21 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- AFX Stock
- 0DHC Stock